ISRCTN10647973已完成2 期
Clobetasol propionate 0.05% versus placebo for the management of erosive oral lichen planus: a randomized controlled trial
niversity of Turin (Italy)0 个研究点目标入组 20 人开始时间: 2015年12月8日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
2018 results in https://www.ncbi.nlm.nih.gov/pubmed/29297958
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Histological diagnosis of OLP on the basis of WHO criteria: hyperkeratosis of the superficial epithelial layers, vacuolar degeneration of the germinative layer of the epithelium and band-like sub-epithelial lymphocytic inflammatory infiltrate
- •2. Presence of painful and atrophic-erosive oral lesions, at the same time with reticular ones
- •3. Ability to complete the present trial
排除标准
- •1. Presence of histological signs of dysplasia
- •2. Use of lichenoid reaction inducing drugs and presence of amalgam fillings close to lesions
- •3. Therapy for OLP in the 2 months prior to the study
- •4. Pregnant or breastfeeding women
- •5. Proved or suspected hypersensitivity caused by the tested chemicals
研究者
相似试验
进行中（未招募）
不适用
Subject preference comparison between Clobetasol propionate shampoo, 0.05 and three other topical corticosteroids in the treatment of moderate to severe scalp psoriasis - NDScalp PsoriasisMedDRA version: 9.1Level: LLTClassification code 10037153Term: PsoriasisEUCTR2006-003073-27-ITGALDERMA R D SNC240
进行中（未招募）
1 期
Subject preference comparison between Clobetasol propionate shampoo, 0.05% and three other topical corticosteroids in the treatment of moderate to severe Scalp psoriasis - Subject preference of topical corticosteroids in scalp psoriasisModerate to Severe Scalp Psoriasis with a Global Severity Score of 3 at least on a scale from 0 to 5.MedDRA version: 8.1 Level: LLT Classification code 10037157 Term: Psoriasis of scalpEUCTR2006-003073-27-GBGalderma R&D240
进行中（未招募）
1 期
Subject preference comparison between Clobetasol propionate shampoo, 0.05% and three other topical corticosteroids in the treatment of moderate to severe Scalp psoriasis - Subject preference of topical corticosteroids in scalp psoriasisModerate to Severe Scalp Psoriasis with a Global Severity Score of 3 at least on a scale from 0 to 5.MedDRA version: 8.1Level: LLTClassification code 10037157Term: Psoriasis of scalpEUCTR2006-003073-27-DEGalderma R&D
Unknown
4 期
Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in AlopeciaAlopeciaNCT01111981Callender Center for Clinical Research30
已完成
不适用
Comparison of efficacy of topical clobetasol 0.05% plus 5FU 5% cream vs. topical clobetasol 0.05% alone in the treatment of vitiligo.Vitiligo.vitiligoIRCT201203049198N2Isfahan Univercity of Medical Sciences45